Brain PET-MRI Systems Market

The global brain PET-MRI systems market size was valued at 294.5 million in 2020 and is anticipated to expand at a substantial CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increasing incidence of neurological disorders.

Get Free Sample Report

Positron emission tomography (PET) provides 3-dimensional and high-resolution imaging of molecular, physiologic, and functional targets. Brain PET-MRI is a two in one test primarily designed to bring out highly detailed pictures of the brain. Although positron emission tomography (PET) captures the image of the whole brain, it has insufficient attenuation, lacks spatial resolution, needs scatter correction, and have low sensitivity. As a result of this, a combined technique with magnetic resonance imaging (MRI) helps overcome the underlying problems. The diagnosis of neurological disorders has improved due to the integration of MRI with PET. The brain’s biochemical and psychological processes of brain can be observed concurrently due to the introduction of new opportunities by brain PET-MRI systems. There are various challenges faced by the brain PET-MRI systems that include appropriate construction of PET-MRI system, placement of PET system and photomultiplier tubes (PMTs) in the high magnetic field, and development of attenuation maps for PET images.

The increase in the spread of COVID-19 pandemic during the peak time of the outbreak has resulted in to rise in demand for new treatments and diagnosis. Several researches show that the pandemic is expected to have an effect on individual’s brain and can be measured accurately with the use of brain PET-MRI. As the number of the cases for psychological impact on the COVID patients are rising, the demand for brain PET-MRI scans is in surge rapidly as it helps to examine and analyze some cognitive impairment and loss in neurological function right away. However, some of the patients started facing such impact only in six months after the diagnosis.

Market Trends, Drivers, Restraints, and Opportunities

• Growing demand for brain PET-MRI systems in pharmaceuticals is anticipated to fuel the market growth during the forecast period.
• Increasing integration of PET with several other radio isotopes in radiopharmaceuticals is expected to boost the market growth.
• Strict, rigid, and rigorous guidelines imposed by governments are projected to restrain the market expansion during the forecast period.
• Installation of brain PET-MRI systems is costly and a challenging task that can act as a major restraining factor of the market growth in the coming years.
• Advancement in diagnostics applications coupled with technological advancements in PET-MRI systems are projected to create lucrative opportunities for market growth.

Scope of the Report

The report on the global brain PET-MRI systems market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Market Segment Insights

Clinical segment is anticipated to expand at a fast pace

On the basis of phases, the global brain PET-MRI systems market is bifurcated into pre-clinical and clinical. The pre-clinical segment held a large share of the market in 2019 and is expected to account for a key market share during the projected period. The segment growth is attributed to the huge number of pre-clinical studies performed on the brain PET-MRI systems in order to understand the efficiency of diagnosis of neurological disorders. However, the clinical segment is anticipated to expand at a fast pace in the coming years owing to the growing number of clinical trials for neurological disorders. At present, more than 250 clinical trials are being conducted for neurological disorders. Effective results are also achieved in the pre-clinical trials that enable the brain PET-MRI systems to enter the clinical trials and drive the segment growth.

Helium-free PET-MRI systems segment is estimated to grow at a high rate

Based on products, the market is divided into helium-free PET-MRI systems and traditional PET-MRI systems. The traditional PET-MRI systems is projected to constitute a robust share of the market in terms of revenue during the forecast period owing to the development of such devices by the key players. On the other hand, the helium-free PET-MRI Systems is estimated to grow at a high rate in the coming years. There are some complications associated with the traditional systems and using the helium-free PET-MRI Systems can overcome the challenges. This is anticipated to boost the market segment growth.

Get Free Sample Report

Diagnostic imaging centers segment is expected to grow at a rapid pace

On the basis of end-users, the global brain PET-MRI systems market is divided into diagnostic imaging centers, hospitals, and others. The hospitals segment constituted a major share of the market in terms of revenue in 2019 and is anticipated to exhibit a robust CAGR during the forecast period due to rising cases of neurological disorders across the globe. Every year, approximately 500,000 cases of amyotrophic lateral sclerosis, multiple sclerosis, and brain tumor are diagnosed and majority of the cases are registered in hospitals that are largely equipped with several advanced systems.

The diagnostic imaging centers segment, however, is expected to grow at a rapid pace during the projected period owing to the preference of diagnostic imaging centers by patients in order to avoid the high cost of procedures and lengthy-time waits associated with the hospitals. Moreover, diagnostic imaging centers provide an enhanced diagnosis by using hybrid imaging devices. On the other hand, the others segment is estimated to grow at a significant CAGR during the forecast period due to the wide installation of these devices by universities and research centers for research purposes in order to understand the effectiveness of these devices in the diagnosis of neurological disorders.

Get Free Sample Report

Asia Pacific is anticipated to register a robust CAGR

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to register a robust CAGR during the forecast period attributed to the rising adoption of diagnostic machines that are advanced by the universities and research centers in the region. On the other hand, North America held a significant share of the market in 2019 and is projected to constitute a major market share in the coming years owing to the increasing incidence of neurological disorders in the region. Meanwhile, the market in Europe is expected to hold a considerable revenue share during the projected period owing to increasing awareness towards hybrid imaging. Educational and training programs are conducted by non-profit organizations for physicists, technologists, and scientists to educate and train people on advanced technologies of hybrid imaging.

Segments

The global brain PET-MRI systems market has been segmented on the basis of

Phases

• Pre-clinical
• Clinical

Products

• Helium-free PET-MRI Systems
• Traditional PET-MRI Systems

End-users

• Diagnostic Imaging Centers
• Hospitals
• Others

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Koninklijke Philips N.V.
• Bruker
• GE Healthcare
• Mediso Ltd.
• Cubresa Inc.
• MR Solutions
• Aspect Imaging
• Siemens Healthineers AG

Competitive Landscape

Key players competing in the global brain PET-MRI systems market are Koninklijke Philips N.V.; Bruker; GE Healthcare; Mediso Ltd.; Cubresa Inc.; MR Solutions; Aspect Imaging; and Siemens Healthineers AG. Many of these players have adopted business strategies such as launch of new products, advancement of technologies, partnerships, mergers, and production capacity expansion in order to increase their consumer base and expand their market position globally. For instance, an alliance was formed between Brightonix Imaging and Aspect Imaging formed for preclinical MRI researchers in order to offer or provide SimPET insert.